Drrx stock news
DRRX Stock Summary. In terms of twelve month growth in earnings before interest and taxes, Durect Corp is reporting a growth rate of -1,510.22%; that's higher Stock analysis for Durect Corp (DRRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Technical stock forecast for DRRX: Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a Durect Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Get the latest DURECT Corporation DRRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and Zacks News for DRRX; Other News for DRRX
DURECT Corporation company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: DRRX | Nasdaq.
2 Jan 2020 PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with 2 Jan 2020 However, this morning DURECT came out with bad news that saw shares plummet. The company announced top-line results from a Phase 2a 23 Dec 2019 DURECT Corporation - DRRX Stock Chart Technical Analysis for 12-23-2019 Subscribe to My MAIN Channel Here: 8 Jan 2020 Big changes are happening at DURECT Corporation (NASDAQ:DRRX), which makes the stock worth watching today. The company is among
DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Lumoxiti is a CD22-directed immunotoxin and a first-in-class The goal of Market News Video is to create a Stock TV atmosphere for both individuals and institutional traders. Investors will be able to visit MarketNewsVideo.com for continuous updates from the world markets with new videos being uploaded… Nejnovější tweety od uživatele Bryon Franzen (@bkfViking123). full time stock trader (10yrs). SGT,MT,MLT(ASCP),BBA,AAS,RSO, scratch golfer,fine artist, https://t.co/vFbhhWMgkA https://t.co/Fbn9s0EH4Y. Nejnovější tweety od uživatele Sofiane (@Sofianemah). #fitness #pilate. Montpellier, France RTTNews delivers the latest news from around the world covering business, economics, politics, forex, market analysis, stocks to watch, entertainment, audio, video and photos. car - Free download as PDF File (.pdf), Text File (.txt) or read online for free. car and driver LOS Angeles, Nov. 15, 2019 /PRNewswire/ -- Discovery Behavioral Health, a nationwide leader in mental health services, has acquired Authentic Recovery Center (ARC), located in West Los Angeles.
31 Dec 2019 Get breaking news and analysis on DURECT Corporation (DRRX) stock, price quote and chart, trading and investing tools.
Cassava Sciences among healthcare gainers; DURECT leads the losers. SA Breaking News 01/02 11:01 ET. Durect's stock tumbles after failed psoriasis trial View DURECT Corporation's fair value, margin of safety, stock price, financial statements, news, valuation models, fundamental charts, and more. 4 Apr 2019 Simply Wall St News. Search If You Had Bought DURECT (NASDAQ:DRRX) Stock A Year Ago, You'd Be Sitting On A 72% Loss, Today. Simply Wall St Specifically, the stock price nose-dived 72% in that time. So it's not Find the latest and the upcoming Durect earnings report Dec 30, 2019 as well as The TipRanks Smart Score analyzes stocks based on 8 factors extracted from
The announcement of clinical trial results is a major market-moving event for pharma/biotech stocks. Listed below are some of the pharma/biotech stocks to watch out for today and tomorrow.
DRRX stock quote, chart and news. Get DURECT Corp.'s stock price today. DRRX stock is currently showing down return of -14.37 throughout last week and witnessed bearish return of 27.27 in one month period. The performance of company 53.01 in three months and 317.16 for the last six months trading period. Volatility: The stock price volatility remained at 11.24 in recent month and reaches at 19.74 for the week. 06/11/2019 · Their average twelve-month price target is $4.20, suggesting that the stock has a possible upside of 57.30%. The high price target for DRRX is $5.50 and the low price target for DRRX is $2.10. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy." On Friday, shares of DURECT Corporation (NASDAQ:DRRX) marked $2.41 per share versus a previous $2.26 closing price. With having a 6.64% gain, an insight into the fundamental values of DURECT Corporation, investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.
8 Jan 2020 Big changes are happening at DURECT Corporation (NASDAQ:DRRX), which makes the stock worth watching today. The company is among 3 Dec 2019 DURECT Corporation (NASDAQ: DRRX): Breakdown Of Prospects Amid Price Fluxes: The Healthcare stock closed with direction of ↑ of its last trading at $2.19 while performing a change of 2.82% Gain on Market News. 10 Dec 2019 It is simply DRRX stock's average closing price over the last 50 days. 50-SMA DRRX stock price current trend is considered pessimistic. in writing financial and business news, most recently as Investment Editor and writer. On Monday, November 04, 2019, by making a change of 4.35% with the Gain (↑), the Healthcare stock (DURECT Corporation) created a change of 3.23% from DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.